Molecular basis for selective advantage of glucose-6-phosphate-dehydrogenase-deficient individuals exposed to malaria.
D000328:Adult; D000818:Animals; D001798:Blood Proteins / Q000096:biosynthesis; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood* / Q000453:epidemiology / Q000235:genetics / Q000378:metabolism; D005971:Glutamates / Q000097:blood / Q000494:pharmacology; D005978:Glutathione / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D006579:Heterozygote; D006801:Humans; D008288:Malaria / Q000097:blood* / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D051379:Mice; D010084:Oxidation-Reduction; D010965:Plasmodium malariae / Q000254:growth & development; D011817:Rabbits; D012156:Reticulocytes / Q000187:drug effects
D001798:Blood Proteins; D005971:Glutamates; D005978:Glutathione